Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

978
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
978
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

627
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
627
Migration00:53

Migration

8.9K
Migration is long-range, seasonal movement from one region or habitat to another. This common strategy, carried out by many different organisms around the world, is an adaptive response that typically corresponds to changes in an organism’s environment, like resource availability or climate. Migrations can involve huge groups of thousands of animals as well as single individuals traveling alone and can range from thousands of kilometers to just a few hundred meters.
8.9K
Cell Migration01:19

Cell Migration

6.6K
Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
6.6K
Cell Migration01:09

Cell Migration

18.8K
Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.
18.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mental health management in the context of TB care in the WHO European Region: a consensus statement.

IJTLD open·2026
Same author

Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocol.

IJTLD open·2026
Same author

Clinical best practices for caring for people with expanded resistance to newer TB drugs.

IJTLD open·2025
Same author

TB screening of children from Ukraine in Germany.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy.

IJTLD open·2025
Same author

Prototype of AI-powered assistance system for digitalisation of manual waste sorting.

Waste management (New York, N.Y.)·2025
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K

[Migration and Tuberculosis].

J T Othmer, N Schönfeld, B Häcker

    Pneumologie (Stuttgart, Germany)
    |August 31, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Tuberculosis in Germany disproportionately affects migrants, with current screening methods missing many cases. Improving healthcare access and building trust are crucial for diagnosing and treating latent tuberculosis in this population.

    More Related Videos

    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
    23:06

    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

    Published on: August 11, 2008

    19.6K
    An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
    09:02

    An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

    Published on: February 17, 2014

    20.3K

    Related Experiment Videos

    Last Updated: Feb 5, 2026

    Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
    10:06

    Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

    Published on: February 26, 2018

    7.8K
    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
    23:06

    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

    Published on: August 11, 2008

    19.6K
    An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
    09:02

    An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

    Published on: February 17, 2014

    20.3K

    Area of Science:

    • Public Health
    • Infectious Diseases
    • Migration Health

    Background:

    • Tuberculosis (TB) predominantly affects migrants in Germany.
    • Current screening under the German Protection against Infection Act (Infektionsschutzgesetz, IfSG) diagnoses only 20-25% of TB cases in migrants.
    • Reactivation of latent TB is the primary cause of TB in migrant populations.

    Purpose of the Study:

    • To highlight challenges in diagnosing and treating tuberculosis in migrants.
    • To emphasize the need for improved healthcare access for latent TB testing and treatment.
    • To underscore the importance of addressing diverse risk factors, comorbidities, and socio-cultural aspects in migrant TB care.

    Main Methods:

    • Analysis of tuberculosis case data in Germany, focusing on the migrant demographic.
    • Evaluation of the effectiveness of existing screening protocols (IfSG).
    • Review of factors influencing TB presentation, diagnosis, and treatment in migrants, including country of origin, comorbidities, and migration-related stress.

    Main Results:

    • Screening methods under IfSG are insufficient for early TB detection in migrants.
    • Latent TB reactivation is the most common form, necessitating accessible healthcare for testing and treatment.
    • Extrapulmonary TB and multi-drug resistant TB require specific diagnostic considerations.
    • Cultural and linguistic barriers, alongside trust issues, impede effective doctor-patient relationships and treatment adherence.

    Conclusions:

    • Enhanced healthcare access and tailored diagnostic approaches are vital for managing TB in migrants.
    • Building trust through empathy and cultural sensitivity is essential for successful treatment completion.
    • Addressing comorbidities and socio-legal factors is crucial for comprehensive TB care in this population.